Patent details

EP2522366 Title: TARGETING AGENT FOR TUMOR SITE

Basic Information

Publication number:
EP2522366
PCT Application Number:
JP2011050178
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117318436
PCT Publication Number:
WO2011083845
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TARGETING AGENT FOR TUMOR SITE
French Title of Invention:
AGENT DE CIBLAGE POUR SITE TUMORAL
German Title of Invention:
ANZIELUNGSMITTEL ZUR TARGETING EINES TUMORS
SPC Number:

Dates

Filing date:
07/01/2011
Grant date:
31/10/2018
EP Publication Date:
14/11/2012
PCT Publication Date:
14/07/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/10/2018
EP B1 Publication Date:
31/10/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/01/2019
Expiration date:
07/01/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/10/2018
 
 

Name:
FUJIFILM Corporation
Address:
26-30, Nishiazabu 2-chome Minato-ku, Tokyo 106-8620, Japan (JP)

Inventor

1

Name:
KOJIMA Masayoshi
Address:
Japan (JP)

2

Name:
OGIWARA Kazutaka
Address:
Japan (JP)

3

Name:
KAKINUMA Chihaya
Address:
Japan (JP)

4

Name:
TAKADA Kiyohito
Address:
Japan (JP)

5

Name:
KAWAKAMI Masayuki
Address:
Japan (JP)

6

Name:
SASAKI Tasuku
Address:
Japan (JP)

7

Name:
OHNO Makoto
Address:
Japan (JP)

Priority

Priority Number:
2010002696
Priority Date:
08/01/2010
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 9/10; A61K 9/127; A61K 49/00; A61K 51/00; A61K 47/42;

Publication

European Patent Bulletin

Issue number:
201844
Publication date:
31/10/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/05/2019 Outgoing Correspondence 1